pharmaceuticals-and-healthcare

EMEA (Europe, Middle East and Africa) Biosimilar Market Report 2017


Published On : Aug 2017

Category : Pharmaceutical

No. of Pages : 104 pages

  • $4000
  • $8000

Please click below to avail discount on this report

In this report, the EMEA Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Biosimilar for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Biosimilar market competition by top manufacturers/players, with Biosimilar sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Roche
Eli Lilly
Bayer
Amgen
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Merck

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Antibody
Hormone
Growth Factors
Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Biosimilar for each application, including
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

If you have any special requirements, please let us know and we will offer you the report as you want.
 

In the recent times, the global market for Emea europe middle east and africa biosimilar market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Emea europe middle east and africa biosimilar market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Emea europe middle east and africa biosimilar market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the Emea europe middle east and africa biosimilar market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Emea europe middle east and africa biosimilar market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Emea europe middle east and africa biosimilar market report 2017, including the definition, classification, and industry chain structure of Emea europe middle east and africa biosimilar market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Emea europe middle east and africa biosimilar market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Emea europe middle east and africa biosimilar market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Emea europe middle east and africa biosimilar market report 2017, implemented in each of the geographical segments. The predominant applications of the Emea europe middle east and africa biosimilar market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Emea europe middle east and africa biosimilar market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Emea europe middle east and africa biosimilar market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Biosimilar
Figure EMEA Biosimilar Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Biosimilar Sales Volume Market Share by Type (Product Category) in 2016
Figure Antibody Product Picture
Figure Hormone Product Picture
Figure Growth Factors Product Picture
Figure Other Product Picture
Figure EMEA Biosimilar Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Biosimilar by Application in 2016
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Hemophilia Examples
Table Key Downstream Customer in Hemophilia
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Biosimilar Market Size (Million USD) by Region (2012-2022)
Figure Europe Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biosimilar Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Biosimilar Revenue (Million USD) Status and Forecast by Countries
Figure Africa Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Biosimilar Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Biosimilar Sales Volume and Growth Rate (2012-2022)
Figure EMEA Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Biosimilar Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Biosimilar Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Biosimilar Sales Share by Players (2012-2017)
Figure 2016 Biosimilar Sales Share by Players
Figure 2017 Biosimilar Sales Share by Players
Figure EMEA Biosimilar Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Biosimilar Revenue (Million USD) by Players (2012-2017)
Table EMEA Biosimilar Revenue Share by Players (2012-2017)
Table 2016 EMEA Biosimilar Revenue Share by Players
Table 2017 EMEA Biosimilar Revenue Share by Players
Table EMEA Biosimilar Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Biosimilar Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Biosimilar Sales Share by Type (2012-2017)
Figure Sales Market Share of Biosimilar by Type (2012-2017)
Figure EMEA Biosimilar Sales Market Share by Type (2012-2017)
Table EMEA Biosimilar Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilar by Type in 2016
Table EMEA Biosimilar Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Biosimilar Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Biosimilar Sales Share by Application (2012-2017)
Figure Sales Market Share of Biosimilar by Application (2012-2017)
Figure EMEA Biosimilar Sales Market Share by Application in 2016
Table EMEA Biosimilar Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Biosimilar Sales Share by Region (2012-2017)
Figure Sales Market Share of Biosimilar by Region (2012-2017)
Figure EMEA Biosimilar Sales Market Share in 2016
Table EMEA Biosimilar Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Biosimilar Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Biosimilar by Region (2012-2017)
Figure EMEA Biosimilar Revenue Market Share Regions in 2016
Table EMEA Biosimilar Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Biosimilar Revenue and Growth Rate (2012-2017)
Table Europe Biosimilar Sales (K Units) by Type (2012-2017)
Table Europe Biosimilar Market Share by Type (2012-2017)
Figure Europe Biosimilar Market Share by Type in 2016
Table Europe Biosimilar Sales (K Units) by Application (2012-2017)
Table Europe Biosimilar Market Share by Application (2012-2017)
Figure Europe Biosimilar Market Share by Application in 2016
Table Europe Biosimilar Sales (K Units) by Countries (2012-2017)
Table Europe Biosimilar Sales Market Share by Countries (2012-2017)
Figure Europe Biosimilar Sales Market Share by Countries (2012-2017)
Figure Europe Biosimilar Sales Market Share by Countries in 2016
Table Europe Biosimilar Revenue (Million USD) by Countries (2012-2017)
Table Europe Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Europe Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Europe Biosimilar Revenue Market Share by Countries in 2016
Figure Germany Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure France Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure UK Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Biosimilar Sales (K Units) by Type (2012-2017)
Table Middle East Biosimilar Market Share by Type (2012-2017)
Figure Middle East Biosimilar Market Share by Type (2012-2017)
Table Middle East Biosimilar Sales (K Units) by Applications (2012-2017)
Table Middle East Biosimilar Market Share by Applications (2012-2017)
Figure Middle East Biosimilar Sales Market Share by Application in 2016
Table Middle East Biosimilar Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Biosimilar Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Biosimilar Sales Volume Market Share by Countries in 2016
Table Middle East Biosimilar Revenue (Million USD) by Countries (2012-2017)
Table Middle East Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Middle East Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Middle East Biosimilar Revenue Market Share by Countries in 2016
Figure Saudi Arabia Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Biosimilar Sales (K Units) by Type (2012-2017)
Table Africa Biosimilar Sales Market Share by Type (2012-2017)
Figure Africa Biosimilar Sales Market Share by Type (2012-2017)
Figure Africa Biosimilar Sales Market Share by Type in 2016
Table Africa Biosimilar Sales (K Units) by Application (2012-2017)
Table Africa Biosimilar Sales Market Share by Application (2012-2017)
Figure Africa Biosimilar Sales Market Share by Application (2012-2017)
Table Africa Biosimilar Sales Volume (K Units) by Countries (2012-2017)
Table Africa Biosimilar Sales Market Share by Countries (2012-2017)
Figure Africa Biosimilar Sales Market Share by Countries (2012-2017)
Figure Africa Biosimilar Sales Market Share by Countries in 2016
Table Africa Biosimilar Revenue (Million USD) by Countries (2012-2017)
Table Africa Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Africa Biosimilar Revenue Market Share by Countries (2012-2017)
Figure Africa Biosimilar Revenue Market Share by Countries in 2016
Figure South Africa Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Table Pfizer Biosimilar Basic Information List
Table Pfizer Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Pfizer Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Roche Biosimilar Basic Information List
Table Roche Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Roche Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Biosimilar Basic Information List
Table Eli Lilly Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Bayer Biosimilar Basic Information List
Table Bayer Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Bayer Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Amgen Biosimilar Basic Information List
Table Amgen Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Amgen Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Sanofi-Aventis Biosimilar Basic Information List
Table Sanofi-Aventis Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi-Aventis Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Sanofi-Aventis Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Biosimilar Basic Information List
Table Johnson & Johnson Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Novo Nordisk Biosimilar Basic Information List
Table Novo Nordisk Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Novo Nordisk Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Merck Biosimilar Basic Information List
Table Merck Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Biosimilar Sales Market Share in EMEA (2012-2017)
Figure Merck Biosimilar Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar
Figure Manufacturing Process Analysis of Biosimilar
Figure Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Major Manufacturers in 2016
Table Major Buyers of Biosimilar
Table Distributors/Traders List
Figure EMEA Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Biosimilar Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Biosimilar Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Biosimilar Sales Market Share Forecast by Region (2017-2022)
Table EMEA Biosimilar Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Biosimilar Revenue Market Share Forecast by Region (2017-2022)
Table Europe Biosimilar Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Biosimilar Sales Market Share Forecast by Countries (2017-2022)
Table Europe Biosimilar Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Biosimilar Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Biosimilar Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Biosimilar Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Biosimilar Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Biosimilar Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Biosimilar Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Biosimilar Sales Market Share Forecast by Countries (2017-2022)
Table Africa Biosimilar Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Biosimilar Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Biosimilar Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Biosimilar Sales Market Share Forecast by Type (2017-2022)
Table EMEA Biosimilar Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Biosimilar Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top